Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,973.0
24.0 (0.81%)

 

  • STI Straits Times Index
    2,973.0
    24.0 (0.81%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,567.1
    -10.6 (-0.67%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,452.6
    472.4 (1.63%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,551.4
    42.3 (1.21%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,663.5
    697.5 (2.41%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,338.5
    96.7 (1.55%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,925.5M
  • Value: 1,621.8M
  • Rise: 184
  • Fall: 171
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.072+0.001
CWX Global0.006-0.001
Thomson Medical0.121+0.002
Jiutian Chemical0.090+0.001
Sembcorp Marine0.153-
YZJ Shipbldg SGD1.080+0.010
Avarga0.325-0.040
Shen Yao0.003-0.001
Jasper Inv0.006-
Secura0.100-0.002

World Indices

World Indices
Name Last Change
Nasdaq 13,192.3 +72.9
HSI 29,452.6 +472.4
HSCEI 11,453.7 +206.5
Jakarta 6,338.5 +96.7
Nikkei 225 29,663.5 +697.5
SSE Comp 3,551.4 +42.3
Shanghai A 3,722.6 +44.4
Shanghai B 246.1 +2.8
KOSPI 3,099.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CLEVER LEAVES HOLDINGS INC CLEVER LEAVES HOLDINGS
Updated on 26 Feb 2021 (End of trading day)
Last (USD): 13.200 Change: -0.630 High: 13.970 Remarks: -
Change (%): -4.56 Low: 12.245
Open 13.500 Yesterday's Close 13.83
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,363,382 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.36666 Trailing EPS (USD) e -3.29521 NAV (USD) b 2.9030
PE a - Trailing PE f - Price / NAV b 4.5470
Dividend (USD) d - Cash In Hand (USD) g 0.5311 Issued & Paid-up Shares c 11,741,600
Dividend Yield (%) d - Price / Cash In Hand g 24.854 Treasury Shares h -
Market Cap (M) 154.989 Enterprise Value (M) 189.929
Piotroski F Score 2 Exchange Code CLVR Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 100.0
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 22 Dec 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 21 Dec 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CLEVER LEAVES HOLDINGS INC NASDAQ 154.989 - - 4.5470 -
Industry Pharmaceuticals: Other NASDAQ 1,718.572 2051.150 - 5.4577 -
Local Peer HORIZON THERAPEUTICS PLC NASDAQ 20,368.204 52.253 52.253 5.0600 -
Local Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 16,843.417 - - 9.2775 -
Local Peer ICON PLC NASDAQ 9,537.754 28.700 28.700 5.1549 -
Local Peer JAZZ PHARMACEUTICALS PLC NASDAQ 9,464.920 39.666 39.666 2.5862 -
Local Peer UNITED THERAPEUTICS CORP NASDAQ 7,446.916 14.466 14.466 2.1934 -
Local Peer GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 NASDAQ 6,713.738 - - 9.0593 -
Local Peer SAGE THERAPEUTICS INC NASDAQ 4,962.462 8.188 8.188 2.3946 -
Local Peer REVOLUTION MEDICINES INC NASDAQ 3,297.059 - - 6.5280 -
Local Peer PACIRA BIOSCIENCES INC NASDAQ 3,193.112 21.942 - 5.1528 -
Local Peer CORCEPT THERAPEUTICS INC NASDAQ 2,950.397 27.831 27.831 5.6376 -
Local Peer AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 2,636.782 - - 4.3815 -
Local Peer AXSOME THERAPEUTICS INC NASDAQ 2,515.505 - - 18.5975 -
Other Local Peers MADRIGAL PHARMACEUTICALS INC (NASDAQ), CASSAVA SCIENCES INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), ZOGENIX INC (NASDAQ), INNOVIVA INC (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), SILENCE THERAPEUTICS PLC SPON ADS EACH REP 3 ORD SHS (NASDAQ), INTERSECT ENT INC (NASDAQ), INTERCEPT PHARMACEUTICALS INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), MEI PHARMA INC (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), CERECOR INC (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), KEMPHARM INC (NASDAQ), BIOPHYTIS SPON ADS EACH REP 10 ORD SHS (NASDAQ), SCYNEXIS INC (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), LIPOCINE INC (NASDAQ), SCOPUS BIOPHARMA INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), GT BIOPHARMA INC (NASDAQ), PLX PHARMA INC (NASDAQ), NATURAL ALTERNATIVES INTERNATIONAL (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), EVOKE PHARMA INC (NASDAQ), QUALIGEN THERAPEUTICS INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), ENVERIC BIOSCIENCES INC (NASDAQ), HAPPINESS BIOTECH GROUP LTD (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), NEOS THERAPEUTICS INC (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), INTEC PHARMA LTD (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ)
Global Peer CATALENT INC NYSE 19,356.512 111.887 66.289 5.6016 -
Global Peer FOSUN PHARMA HKEx 97,518.383 25.891 24.991 2.6986 1.130
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 11,173.580 - - 20.8854 -
Global Peer PERRIGO COMPANY PLC NYSE 5,508.777 37.706 - 0.9465 2.026
Global Peer Kalbe Farma Tbk. IDX 71,246,846.000 28.422 27.207 4.1774 1.316
Global Peer LIVZON PHARMA HKEx 27,185.353 18.401 14.571 2.0595 4.307
Global Peer BELLRING BRANDS INC NYSE 3,112.265 132.440 123.014 -1.2451 -
Global Peer SIHUAN PHARM HKEx 22,717.632 - - 2.4043 0.771
Global Peer LUYE PHARMA HKEx 21,706.144 13.035 15.767 2.5837 1.874
Global Peer PRESTIGE CONSUMER HEALTHCARE INC NYSE 2,079.861 14.618 12.513 1.5718 -
Other Global Peers BLACKMORES LTD (ASX), MEGA (SET), FUDANZHANGJIANG (HKEx), HEC PHARM (HKEx), TONG REN TANG (HKEx), HBM HOLDINGS-B (HKEx), CLINUVEL PHARMACEUTICALS LTD (ASX), Indofarma Tbk. (IDX), Tianjin ZX USD (SGX), OCI INTL (HKEx), SHANDONG XINHUA (HKEx), CONSUN PHARMA (HKEx), DOD (SET), GOLDEN THROAT (HKEx), AMPIO PHARMACEUTICALS INC (NYSE American), ALTHEA GROUP HOLDINGS LTD (ASX), LANSEN PHARMA (HKEx), BOTANIX PHARMACEUTICALS LTD (ASX), ANTISENSE THERAPEUTICS (ASX), ISORAY INC (NYSE American), YSPSAH (Bursa), C HEALTH GP (HKEx), VITA LIFE SCIENCES LIMITED (ASX), Pyridam Farma Tbk (IDX), EAGLE HEALTH HOLDINGS LTD (ASX), IDT AUSTRALIA LIMITED (ASX), PHARMAUST LIMITED (ASX), NUTRITIONAL GROWTH SOLUTIONS LTD (ASX), CRONOS AUSTRALIA LIMITED (ASX), CANNPAL ANIMAL THERAPEUTICS LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.550
-10.51 %
10 Days --4.760
-26.50 %
20 Days -+4.170
+46.18 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.020 - 19.460 Change From 1 Year Low +5.180 % Change From 1 Year Low (%) +64.59
Change From 1 Year High -6.260 % Change From 1 Year High (%) -32.17
2 Years Range 8.020 - 19.460 Change From 2 Years Low +5.180 % Change From 2 Years Low (%) +64.59
Change From 2 Years High -6.260 % Change From 2 Years High (%) -32.17
5 Years Range 8.020 - 19.460 Change From 5 Years Low +5.180 % Change From 5 Years Low (%) +64.59
Change From 5 Years High -6.260 % Change From 5 Years High (%) -32.17
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Clever Leaves Holdings, Inc. operates as a holding company. It produces pharmaceutical-grade cannabinoids. The company was founded on July 23, 2020 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Feb 2021 13.500 13.970 12.245 13.200 2,363,382 -
25 Feb 2021 14.400 14.890 13.256 13.830 679,810 -
24 Feb 2021 14.330 15.250 14.078 14.200 767,538 -
23 Feb 2021 13.500 14.340 12.850 14.300 1,209,757 -
22 Feb 2021 15.500 15.660 14.410 14.750 1,208,457 -
19 Feb 2021 16.350 17.490 16.020 16.060 834,615 -
18 Feb 2021 16.990 17.454 15.560 16.150 961,398 -
17 Feb 2021 18.190 18.870 17.060 17.220 1,332,337 -
16 Feb 2021 18.980 19.400 17.700 19.200 2,387,138 -
12 Feb 2021 15.450 19.460 15.080 17.960 5,218,464 -
11 Feb 2021 17.260 17.480 14.900 15.820 4,554,524 -
10 Feb 2021 15.139 19.300 14.900 18.170 9,142,934 -
09 Feb 2021 12.699 13.700 11.714 12.930 2,527,953 -
08 Feb 2021 11.730 11.750 11.220 11.750 1,033,755 -
05 Feb 2021 10.850 11.490 10.340 11.010 1,309,364 -
04 Feb 2021 11.220 11.400 10.240 10.550 1,027,145 -
03 Feb 2021 11.254 12.150 10.750 11.040 2,242,406 -
02 Feb 2021 8.960 10.970 8.960 10.480 3,090,128 -
01 Feb 2021 8.980 9.100 8.630 9.030 486,059 -
29 Jan 2021 8.950 9.600 8.659 8.900 968,176 -
28 Jan 2021 8.920 9.380 8.600 9.110 636,563 -
27 Jan 2021 9.000 9.300 8.550 8.800 1,068,907 -
Summary
Current 2 Weeks
(12 Feb 2021 to 26 Feb 2021)
15.450 19.460 12.245 13.200 16,962,896 -
Previous 2 Weeks
(29 Jan 2021 to 11 Feb 2021)
8.950 19.460 8.659 15.820 26,382,444 -
4 Weeks from
(30 Dec 2020 to 28 Jan 2021)
10.500 19.460 9.830 9.110 22,359,341 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.